Heparin in the prevention of deep vein thrombosis after myocardial infarction.
A trial of continuous intravenous heparin in the prevention of deep vein thrombosis was undertaken in 48 patients who had suffered a myocardial infarction. Of the 24 control patients who did not receive heparin seven (29%) developed calf vein thrombosis as detected by the radioactive fibrinogen technique. None of the 24 heparinized patients had any evidence of venous thrombosis. This difference is significant at the 1% level.
D000368:Aged; D002986:Clinical Trials as Topic; D005260:Female; D005340:Fibrinogen; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D007457:Iodine Radioisotopes; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*; D013924:Thrombophlebitis / Q000209:etiology / Q000517:prevention & control*
D007457:Iodine Radioisotopes; D005340:Fibrinogen; D006493:Heparin